Metabolism of bladder cancer represents a key issue for cancer research. Several metabolic
altered pathways are involved in bladder tumorigenesis, representing therefore interesting …

Bladder cancer is the most common malignancy of the urinary tract, presents the highest
recurrence rate among solid tumors and is the second leading cause of death in …

Muscle invasive bladder cancer (MIBC, stage≥ T2) is generally associated with poor
prognosis, constituting the second most common cause of death among genitourinary …

There is growing evidence of the presence of cancer stem cells in urothelial carcinoma.
Cancer stem cells have the ability to self‐renew and to differentiate into all cell types of the …

Urothelial carcinoma is a highly heterogeneous disease that develops along two distinct
biological tracks as evident by candidate gene analysis and genome-wide screening and …

The association between inflammation and cancer has been pointed out in epidemiological
and clinical studies, revealing how chronic inflammation may contribute to carcinogenesis in …

Bladder cancer (BC), the most common cancer arising from the human urinary tract, consists
of two major clinicopathological phenotypes: muscle-invasive bladder cancer (MIBC) and …

The rapid development of the cancer stem cells (CSC) field, together with powerful genome-
wide screening techniques, have provided the basis for the development of future alternative …

Background: In human populations, a certain amount of data correlate obesity/body mass
index (BMI) with urothelial cancer (UC) and prostate cancer (PCa) occurrence, however this …

Unmet needs in urothelial cancer management represent an important challenge in our
effort to improve long-term overall and disease-free survival rates with no significant …